Jeffrey Nugent joined Sientra in 2014 as a board member, prior to becoming the Chairman and CEO in 2015. Mr. Nugent’s experience includes serving as the CEO and Worldwide President of Neutrogena, where he led the acquisition by Johnson & Johnson. Neutrogena is regarded as one of the most successful acquisitions in J&J history. Following Neutrogena, Mr. Nugent became the President and CEO of Revlon, where he led a turnaround in profitability and a global initiative of new product innovation. He was Founder, President and CEO of Precision Dermatology, a multi-channel dermatology and skin care company he established in 2010. The company grew both organically and by M&A and was acquired by Valeant Pharmaceuticals in 2013. He began his career at Johnson & Johnson where he held a number of senior responsibilities in general management, research, finance, marketing and manufacturing across pharmaceutical, medical device and consumer franchises. He was appointed Vice President of Worldwide Quality. Most recently, Mr. Nugent had been Interim President, Chief Executive Officer and a Director of Biolase, Inc. Mr. Nugent has also served as Chairman, Director, President and Chief Executive Officer of a number of aesthetic medicine, medical device and consumer focused companies including Bioform, Inc. prior to its acquisition by Merz Aesthetics, Inc. He has also served on the Board of the Child Welfare League of America. Mr. Nugent holds a BS in mathematics from St. Joseph’s College and earned an MBA in finance and marketing from Loyola University in Chicago. He served as an Artillery Officer in the U.S. Army while assigned to military intelligence at the Pentagon.